Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional and structural characterization of Norovirus GII.6 in recognizing histo-blood group antigens. | Virol Sin | 2023 | 36216242 | PubTator, text mining | PubMed |
| Circulating rotavirus P[8]-lineage IV, unlike P[8]-lineage III, significantly related to nonsecretors status in Iranian children. | J Med Virol | 2023 | 36123611 | PubTator, text mining | PubMed |
| Saliva proteomic profile of early childhood caries and caries-free children. | Acta Odontol Scand | 2023 | 36063428 | PubTator, text mining | PubMed |
| Patients with hypercortisolemic Cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis. | Haematologica | 2023 | 35861015 | PubTator, text mining | PubMed |
| Resveratrol plus low-dose hydroxyurea compared to high-dose hydroxyurea alone is more effective in γ-globin gene expression and ROS reduction in K562 cells. | Nat Prod Res | 2023 | 35776113 | PubTator, text mining | PubMed |
| The journey from blue to pink-a rare cause for self-limiting methemoglobinemia in an Indian baby. | Case Rep Perinat Med | 2022 | 40041223 | PubTator, text mining | PubMed |
| Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives. | Med Rev (2021) | 2022 | 37724161 | PubTator, text mining | PubMed |
| Carrier strategies boost the application of CRISPR/Cas system in gene therapy. | Exploration (Beijing) | 2022 | 37323878 | PubTator, text mining | PubMed |
| Current advances of CRISPR-Cas technology in cell therapy. | Cell Insight | 2022 | 37193354 | PubTator, text mining | PubMed |
| A single-cell comparison of adult and fetal human epicardium defines the age-associated changes in epicardial activity. | Nat Cardiovasc Res | 2022 | 36938497 | PubTator, text mining | PubMed |
| Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature. | Front Immunol | 2022 | 36713414 | PubTator, text mining | PubMed |
| Clinical genome editing to treat sickle cell disease-A brief update. | Front Med (Lausanne) | 2022 | 36698803 | PubTator, text mining | PubMed |
| DNA Methylation: Genomewide Distribution, Regulatory Mechanism and Therapy Target. | Acta Naturae | 2022 | 36694897 | PubTator, text mining | PubMed |
| CRISPR medicine for blood disorders: Progress and challenges in delivery. | Front Genome Ed | 2022 | 36687779 | PubTator, text mining | PubMed |
| mRNA COVID-19 Vaccines-Facts and Hypotheses on Fragmentation and Encapsulation. | Vaccines (Basel) | 2022 | 36679885 | PubTator, text mining | PubMed |
| Identification of ferroptosis-related gene signatures associated with multiple sclerosis using weighted gene co-expression network analysis. | Medicine (Baltimore) | 2022 | 36595760 | PubTator, text mining | PubMed |
| A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin. | ACS Cent Sci | 2022 | 36589886 | PubTator, text mining | PubMed |
| Deficiency of ribosomal protein S26, which is mutated in a subset of patients with Diamond Blackfan anemia, impairs erythroid differentiation. | Front Genet | 2022 | 36579335 | PubTator, text mining | PubMed |
| The role of erythrocytes and erythroid progenitor cells in tumors. | Open Life Sci | 2022 | 36567722 | PubTator, text mining | PubMed |
| Regulation of eIF4E guides a unique translational program to control erythroid maturation. | Sci Adv | 2022 | 36563140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=25